Nigeria has received 11,200 doses of mpox vaccines, part of a broader initiative to combat the mpox outbreak. The vaccines arrived in Abuja on December 20, 2024.
The United States has contributed a batch of 11,200 vaccine doses, produced by Bavarian Nordic. This consignment forms part of the worldwide effort against mpox, still classified as a Public Health Emergency of International Concern.
Through Gavi, the Vaccine Alliance, the United States committed 305,000 doses to aid the international mpox response. Allocation of these vaccines to nations in need is being handled through the Access and Allocation Mechanism for mpox.
Gavi’s chief executive, Dr. Sania Nishtar, thanked the United States for its contribution, saying, “We thank the US for these donations, which substantially strengthen the global mpox response.”
By pledging more than one million mpox vaccine doses for use abroad, the U.S. government highlights the need for worldwide cooperation against viral diseases. Dawn O’Connell, the Assistant Secretary for Preparedness and Response, observed, “Viruses don’t respect borders, and both international and domestic mpox coordination remains a top priority.”
Beyond arranging vaccine donations, Gavi has allocated emergency money to aid the distribution of shots in several nations such as the Democratic Republic of the Congo and Rwanda. The group intends to draw on its First Response Fund to pay for the transportation expenses of the vaccines it acquires or helps deliver.
Receiving these doses in Nigeria may represent a major advance in the nation’s campaign to limit mpox transmission and safeguard public health. While the world keeps addressing this emergency, joint actions and prompt vaccine deliveries are essential for lessening the outbreak’s effects.
